Functional proteomic analysis of melanoma progression
- PMID: 14583466
Functional proteomic analysis of melanoma progression
Abstract
Functional proteomics provides a powerful approach to screen for alterations in protein expression and posttranslational modifications under conditions of human disease. In this study, we use protein screening to examine markers of melanoma progression, by profiling melanocyte versus melanoma cell lines using two-dimensional electrophoresis and mass spectrometry. Eight candidate markers were identified as differentially regulated in transformed cells. In particular, hepatoma-derived growth factor (HDGF) and nucleophosmin B23 were strongly correlated with melanoma. Nucleophosmin B23 is a nucleolar and centrosome-associated protein, which has been implicated as a _target for cyclin E/cyclin-dependent kinase 2 (CDK2) in modulating centrosome duplication and cell cycle control. Western blotting of one-dimensional and two-dimensional gels showed that the form of nucleophosmin B23 that is up-regulated in melanoma represents a posttranslationally modified form, most likely reflecting enhanced phosphorylation in the tumor-derived cells. In contrast, Western analysis of HDGF demonstrated increased expression of all forms in melanoma cell lines compared with melanocytes. Immunohistochemical analysis of human tissue biopsies showed strong expression of HDGF in early and late stage melanomas and low expression in melanocytes and nontumorigenic nevi. Interestingly, biopsies of nevi showed a graded effect in which HDGF immunoreactivity was reduced in nevoid nests penetrating deep into the dermis compared with nests at the epidermal-dermal junction, suggesting that HDGF expression in nevi is dependent on epidermal cell interactions. In contrast, biopsies of melanoma showed strong expression of HDGF throughout the tumor, including cells located deeply within dermis. Thus, expression of this antigen likely reports a reduced dependence of protein expression on epidermal interactions.
Similar articles
-
Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].PLoS One. 2013;8(3):e59345. doi: 10.1371/journal.pone.0059345. Epub 2013 Mar 25. PLoS One. 2013. PMID: 23536873 Free PMC article.
-
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases.Melanoma Res. 2005 Aug;15(4):235-44. doi: 10.1097/00008390-200508000-00002. Melanoma Res. 2005. PMID: 16034300
-
Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.J Cutan Pathol. 2004 Jan;31(1):1-7. doi: 10.1046/j.0303-6987.2004.0106.x. J Cutan Pathol. 2004. PMID: 14675278
-
The role of nucleophosmin in centrosome duplication.Oncogene. 2002 Sep 9;21(40):6170-4. doi: 10.1038/sj.onc.1205708. Oncogene. 2002. PMID: 12214246 Review.
-
Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.Oncogene. 2003 May 19;22(20):3081-6. doi: 10.1038/sj.onc.1206463. Oncogene. 2003. PMID: 12789284 Review.
Cited by
-
Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study.Mol Cancer. 2010 Aug 4;9:207. doi: 10.1186/1476-4598-9-207. Mol Cancer. 2010. PMID: 20684763 Free PMC article.
-
NPM1 as a potential therapeutic _target for atypical teratoid/rhabdoid tumors.BMC Cancer. 2019 Aug 28;19(1):848. doi: 10.1186/s12885-019-6044-z. BMC Cancer. 2019. PMID: 31462227 Free PMC article.
-
Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation.BMC Cancer. 2011 Oct 20;11:457. doi: 10.1186/1471-2407-11-457. BMC Cancer. 2011. PMID: 22014102 Free PMC article.
-
Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.J Neurooncol. 2012 Mar;107(1):101-9. doi: 10.1007/s11060-011-0733-z. Epub 2011 Oct 26. J Neurooncol. 2012. PMID: 22037800
-
Hepatoma-derived growth factor and its role in keloid pathogenesis.J Cell Mol Med. 2010 Jun;14(6A):1328-37. doi: 10.1111/j.1582-4934.2009.00779.x. Epub 2009 May 11. J Cell Mol Med. 2010. PMID: 19432814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical